Selenium Ameliorate Peripheral Nerve Ischemic-Reperfusion Injury via Decreased TNF-α.
Selenium is considered as a trace element that plays antioxidant role in the body. So, the aim of this study was to evaluate the effect of selenium on ameliorating of sciatic nerve ischemia-reperfusion injury. Eighty (80) adult male Wistar rats weighing 250-300 g were used. They were divided into 10 groups (n = 8). Then, femoral vessels were obstructed by using 4/0 silk and splitknot techniques. After 3-h ischemia for all the groups, reperfusion was applied for different periods: 3, 7, 14, and 28 days. In half of each experimental group, 0.2 mg/kg selenium was injected intraperitoneally, coinciding with ischemia. After reperfusion, according to the grouping, rats were killed by using high dose of anesthetic drug and then sciatic nerve was removed and fixed. Then, tissue samples were processed and subsequently stained with hematoxylin-eosin, apoptosis, and immunohistochemistry stains. On the third day of reperfusion, the amount of TNF-α as an inflammatory marker of ischemia-reperfusion acute phase increased. On the seventh day of reperfusion, the amount of NF-кB as an apoptotic index and infiltration of mast cells increased in the tissue as a result of development of inflammation. But, on the 14th day of reperfusion, the amount of NF-кB as an apoptotic index decreased to the lowest amount. On the 28th day of reperfusion, the amount of TNF-α as an inflammatory marker decreased to its lowest level. Prescription of selenium concurrent with development of ischemia can reduce the damage caused by sciatic nerve ischemia-reperfusion.
Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.|Department of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Abolfazl
A
Zendedel
Department of Anatomical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran.
Zahra
Z
Gharibi
Department of Social Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Khatereh
K
Anbari
Department of Surgery, Lorestan University of Medical Sciences, Khorramabad, Iran.
Abolfazl
A
Abbaszadeh
Department of Surgery, Lorestan University of Medical Sciences, Khorramabad, Iran.
Zahra Khanipour
ZK
Khayat
Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Reza Mohammadrezaei
RM
Khorramabadi
Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Maryam
M
Soleymaninejad
Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. rezagholami57@gmail.com.|Department of Anatomical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran. rezagholami57@gmail.com.
Mohammadreza
M
Gholami
D000818:Animals; D004195:Disease Models, Animal; D007274:Injections, Intraperitoneal; D007511:Ischemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D010525:Peripheral Nerves / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D012643:Selenium / Q000008:administration & dosage / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
D014409:Tumor Necrosis Factor-alpha; D012643:Selenium
Ischemia; Sciatic nerve; Selenium; TNF-α